Delivery Order SPE2DB20D2002-SPE2DB25FL58Z
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $9,404.28 to supply Boostrix TDAP vaccine in 0.5mL syringe format, with an ultimate completion date of September 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreements with DLA. The vaccine will be performed at the contractor's location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $71,577.02 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,435.48 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in syringe format (0.5mL). This non-set-aside contract, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a firm fixed-price delivery order. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and a key distribution hub for the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in syringe form (0.5mL) with a ceiling value of $1,064.40. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract utilizes no set-aside designation and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,109.28 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in syringe form (0.5mL). The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5ML) valued at $1,044.92 under a firm fixed price contract with an ultimate completion date of August 28, 2025. This non-set-aside award represents a single delivery order positioned as a child contract, leveraging the company's extensive pharmaceutical supply capabilities and established federal procurement relationships. The vaccine delivery will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $7,836.90 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringe format. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of September 10, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) with a contract ceiling value of $7,909.80. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ml syringe format, valued at $3,918.45 under a firm fixed-price contract type. The award was made on August 22, 2025, with an ultimate completion date of August 25, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $52,873.75 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL58ZDelivery Order
The Defense Logistics Agency (DLA) awarded a $10,910.10 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5 mL syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 24, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order was competitively awarded and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical leverages this contract vehicle to meet critical immunization needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's capability to fulfill this vaccine order reflects its established position as a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 7/23/25 |